Rosuvastatin (all strengths): Supply issue
Viatris, the supplier, advises that there were delays at the factory, which has lead to limited supply of Viatris brand rosuvastatin tablets.
23 March 2026 | Rosuvastatin Sandoz funded
Over the coming months, stock of all strengths of Rosuvastatin Viatris will run out. The supplier has arranged supply of Rosuvastatin Sandoz in its place. The 5 mg and 20 mg strengths are already funded and the 10 mg and 40 mg strengths will be funded from 1 April 2026.
The Viatris 40 mg will be temporarily replaced by the Sandoz brand during April 2026.
Affected product
There was a delay at the factory which delayed some shipments of Rosuvastatin Viatris tablets.
| Strength | Pharmacode | Subsidy | Measure/Qty |
|---|---|---|---|
| 5 mg | 2651130 | $1.29 | per 30 |
| 10 mg | 2651149 | $1.69 | per 30 |
| 20 mg | 2651157 | $2.71 | per 30 |
| 40 mg | 2651165 | $4.55 | per 30 |
Alternative brand
The supplier is supplying Rosuvastatin - Sandoz as an alternative. All presentations have been funded since April 2026.
| Strength | Pharmacode | Subsidy |
Measure |
|---|---|---|---|
| 5 mg | 2716712 | $4.21 | per 30 |
| 10 mg | 2716720 | $4.21 | per 30 |
| 20 mg | 2716739 | $4.21 | per 30 |
| 40 mg | 2716747 | $4.55 | per 30 |
The Sandoz Rosuvastatin brand is Medsafe registered. It contains the same active ingredient in the same amount and it is designed to work in the body the same way.
This brand is also registered for use in Australia. The image of the tablets is sourced from the NPS website.
Rosuvastatin Sandoz Information Sheets NPS Medicinewise(external link)
- March 2026 rosuvastatin supply issue flyer [PDF 189 KB]
Expected resupply 2026
We are working with the supplier to understand when the Viatris brand will be available again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)